CLINICAL_TRIALS
trial_result
· 2025-02-18
Clinical Trial Update: SENSING-AI in Patients With Long COVID (SENSING-AI)
Summary
The SENSING-AI clinical trial in patients with Post-acute COVID-19 syndrome has completed (NCT06247332). Sponsor: Adhera Health, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Adhera Health, Inc. | Conditions: Post-acute COVID-19 Syndrome | Status: COMPLETED